Cisplatin
Therapy prevents neuropathic effects of cisplatin chemotherapy
Published in Drug Week, October 18th, 2002
Cisplatin is just one of several compounds typically incorporated into cancer chemotherapy regimens. One of the side effects of cisplatin is sensory neuropathy, a complication compounded by increased dosing. Neurotrophin-3 (NT-3) gene therapy may avert or reduce sensory complications in patients on cisplatin, according to a new study.
"Neurotrophin-3 (NT-3) promotes the survival of the large fiber sensory neurones that are impaired in cisplatin-induced neuropathy, and may therefore serve as a preventive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2002-10-18)
More Articles from Drug Week
- Prostate Cancer
Study expands look at high-dose vitamin D with docetaxel for patients with advanced disease - HIV/AIDS Therapy
Diketo derivatives show limited promise in lab tests - Hepatitis B
FDA approves new treatment - Idiopathic Pulmonary Fibrosis
Phase III data of Actimmune demonstrate survival benefit - Infectious Disease Therapy
GSQ1530 could be effective against drug-resistant microbes - Skin Cancer
Experimental compound inhibits DNA skin cell damage - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
